Chronic Stress and Visceral Pain: Role of Intestinal Barrier Dysfunction
Chronic Stress and Visceral Pain: Role of Intestinal Barrier Dysfunction
批准号:
9489492
负责人:
SHUANGSONG HONG
金额:
$10.08万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2018-07-31
关键词:
Abdominal PainAcuteAffectAgonistAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAreaBiological AssayChargeChronicChronic stressClinicClinicalColonComplexCorticosteroneDataDevelopmentDiagnosisDistalDown-RegulationEpithelialFoundationsFunctional disorderGastroenterologyGene SilencingGeneral PopulationGlucocorticoid ReceptorHarvestHumanHuman Cell LineHydrocortisoneHyperalgesiaImpairmentIn SituIn VitroInflammatoryInterleukin-6IntestinesInvestigationIrritable Bowel SyndromeLongitudinal StudiesMeasuresMediatingModelingMolecularMucous MembraneNociceptionOutpatientsPainPathogenesisPathway interactionsPatientsPerceptionPermeabilityPharmaceutical PreparationsProductionProteinsRattusRoleSmall Interfering RNASpinalSpinal GangliaStressTight JunctionsTimeTissuesVisceralVisceral painWatercentral sensitizationcytokineglucocorticoid-induced orphan receptorhypothalamic-pituitary-adrenal axisin vivomacromoleculepreventprotein expressionprotein functionresponse
中文摘要
摘要
慢性应激与人类内脏痛觉增强(内脏痛觉过敏)有关
动物模型。临床上慢性应激相关内脏痛觉过敏的一个例子是肠易激
综合征,胃肠病最常见的门诊诊断,影响10%-15%的普通患者
人口。慢性应激性内脏痛的通路、细胞和分子机制
是一个活跃的研究领域,没有潜在的统一机制来解释发病机制,
虽然下丘脑-垂体-肾上腺轴的改变被普遍认为是一个促成因素。
最近的研究表明,慢性应激与肠道屏障功能受损、增加有关
上皮细胞旁对大分子的通透性和内脏痛觉过敏。目前还不清楚
肠屏障功能受损是慢性应激性内脏病变发生的先决条件
痛觉过敏。慢性应激是否直接或间接改变上皮紧密连接也是未知的。
蛋白表达,从而增加肠道通透性,最终激活伤害性感受
小路。这个R21应用程序检验了一种挑衅性的假设,即慢性应激诱导的损伤在
肠上皮紧密连接蛋白的表达和功能是脏器发育的先决条件
痛觉过敏。特异性肠上皮紧密连接蛋白的下调是由
应激诱导促炎细胞因子(S)增加,导致细胞旁通透性增加,以及
初级传入伤害性感受通路的激活。强劲的初步数据支持了这一观点的正确性
假设。特定目标1将研究肠道上皮细胞增加之间的潜在因果关系
慢性应激时细胞旁通透性和增强的内脏痛觉。我们假设慢性病
应激与肠道屏障功能受损有关,这种功能先于内脏痛觉过敏,并涉及
增加了对带电和未带电大分子的渗透性。《特定目标2》将阐明
慢性应激所致肠屏障功能损害的分子途径
痛觉过敏。我们假设慢性应激会导致特定的促炎细胞因子升高,
包括IL-6,它先于并介导特定的肠上皮紧密连接的下调
蛋白质,增加大分子通透性,从而导致内脏痛觉过敏。我们建议
促炎细胞因子(S)升高和肠(结肠)上皮细胞旁细胞增多
大分子的渗透性是产生内脏痛觉过敏所必需的。我们认为这些数据
由R21生成,将构成极具竞争力的R01应用程序的基础。
英文摘要
Abstract
Chronic stress is associated with enhanced visceral pain perception (visceral hyperalgesia) in the human and
animal models. An example of chronic stress-associated visceral hyperalgesia in the clinic is Irritable Bowel
Syndrome, the most common outpatient diagnosis in Gastroenterology, affecting 10-15% of the general
population. The pathways, cellular and molecular mechanisms underlying chronic stress-induced visceral pain
are an active area of investigation without a potentially unifying mechanism to explain the pathogenesis,
although alterations in the Hypothalamic-Pituitary-Adrenal axis are generally accepted as a contributing factor.
Recent studies suggest that chronic stress is associated with impaired intestinal barrier function, increased
epithelial paracellular permeability to macromolecules and visceral hyperalgesia. It is unknown whether
impaired intestinal barrier function is a prerequisite for the development of chronic stress-induced visceral
hyperalgesia. It is also unknown whether chronic stress directly or indirectly alters epithelial tight junction
protein expression and, thereby, increases intestinal permeability culminating in activation of nociceptive
pathways. This R21 application examine the provocative hypothesis that chronic stress-induced impairment in
intestinal epithelial tight junction protein expression and function is a prerequisite for development of visceral
hyperalgesia. Down-regulation involving specific intestinal epithelial tight junction proteins is mediated by
stress-induced increase in pro-inflammatory cytokine(s) resulting in increased paracellular permeability, and
activation of primary afferent nociceptive pathways. Strong preliminary data supports the validity of this
hypothesis. Specific Aim 1 will examine a potential causal role between increases in intestinal epithelial
paracellular permeability and enhanced visceral pain perception in chronic stress. We hypothesize that chronic
stress is associated with impaired intestinal barrier function that precedes visceral hyperalgesia and involves
increased permeability to both charged and uncharged macromolecules. Specific Aim 2 will elucidate the
molecular pathway that underlies chronic stress-mediated impairment in intestinal barrier function and
hyperalgesia. We hypothesize that chronic stress causes elevation in specific pro-inflammatory cytokines,
including IL-6, which precedes and mediates down-regulation of specific intestinal epithelial tight junction
proteins, increase in macromolecular permeability and consequently visceral hyperalgesia. We propose that
both elevation of pro-inflammatory cytokine(s) and increased intestinal (colon) epithelial paracellular
permeability to macromolecules are required to produce visceral hyperalgesia. We believe that the data
generated with the R21 will form the foundation of a highly competitive R01 application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Pathways in Chronic Stress-associated Visceral Hyperalgesia
-
批准号:10248001
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:SHUANGSONG HONG
-
依托单位:
Chronic Stress and Visceral Pain Heterogeneity: Role of Endocannabinoid & Epigenetic Regulatory Pathways
-
批准号:9808182
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:SHUANGSONG HONG
-
依托单位:
Chronic Stress and Visceral Pain: Role of Intestinal Barrier Dysfunction
-
批准号:9167138
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2016
-
负责人:SHUANGSONG HONG
-
依托单位:
海外基金